Vaccine Stabilization Technology



Typical vaccine storage and transportation conditions require refrigeration. At THL we have focused on the formulation of novel stabilization agents for labile drugs that can remove the need for refrigerated storage. Our technology has shown impressive results in several drug candidates at elevated temperatures up to 65° C.


Contact Us